| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |